BME Launches Speed Arc™ Nitinol Bone Fixation Implant For Sloping Surfaces

SAN ANTONIO, Dec. 4, 2014 /PRNewswire/ -- BioMedical Enterprises (BME) announced the launch of the Speed Arc Nitinol Fixation System, the world's first superelastic shape memory fixation device that conforms to the sloping surface of the metaphyseal anatomy. This addition to the current patented BME Speed Fixation System is available in three different sizes to ensure a proper fit in varying patient anatomies.   

Ideal for proximal and distal Akin osteotomies of the foot, the Speed Arc has the same great features as BME's current Speed system:  constant compression to optimize healing, implant pre-loaded on a patent-pending insertion tool for ease of use and pre-sterilized, disposable instrumentation for simplified operating room logistics.

"The launch of the Speed Arc implant is yet another testament to BME's commitment to providing technical advancements in every new product we release to the market.  We will continue to set the bar higher to meet customer expectations with our innovative products."

Dr. John Anderson, DPM, FACFAS, Podiatry Associates of Florida stated, "BME, a leader in Nitinol fixation in extremity surgery, is leading the way in developing implants that not only allow for continuous compression, but also contour to the slope or position of the bone. That is exactly what they have accomplished with the Speed Arc Staple. With the combined advancement of the contouring slope (anatomical design) of the implant and the continuous compression afforded by BME's Nitinol fixation, the Speed Arc offers an excellent solution for fusions and osteotomies for any surgeon." 

The new BME Speed Arc Nitinol Fixation System is available now for commercial use throughout the United States.   

To learn more about BME's new Speed Arc System, visit www.bme-tx.com or call 800-880-6528.

About BME, Inc.

BME, Inc. is a privately-held leader in orthopedic shape memory implant technology for small bone fixation and the only U.S. manufacturer of Nitinol metal implants for musculoskeletal and soft tissue fixation. 

For over a decade, BME has spearheaded the innovation of the Nitinol technologies in the U.S. market, and continues the advancement of Nitinol implants and instruments.  This is accomplished by BME developing new standards for manufacturing processes, adding to its surgeon advisory boards, and focusing on the education of our surgeon communities on the clinical benefits of the Nitinol technology.  Innovation and strategic partnerships will further define the role of BME as leaders, as demonstrated in our commitment to the BME surgeon and patients.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bme-launches-speed-arc-nitinol-bone-fixation-implant-for-sloping-surfaces-300004984.html

SOURCE BME, Inc.

Related Links

http://www.bme-tx.com